All News
Case study links inflammation to HIV persistence in specific scenarios
AIDS and Cancer Virus ProgramPosted 8/7/2023A years-long case study has potentially identified another factor with which HIV treatment efforts must contend: Inflammation could be a linchpin in the virus’ overexpression in some people.
The findings come from the treatment of a person living with HIV. The study, led by the HIV Dynamics and Replication Program at the National Cancer Institute at Frederick and the…
End of NCI-MATCH trial positions precision medicine and genetic sequencing for next big push
Molecular Characterization LaboratoryPosted 8/3/2023NCI-MATCH, one of the largest cancer precision medicine clinical trials to date, closed in 2023 and its follow-on studies will use a similar model to test combinations of treatments, evaluating a patient’s immune system prior to pairing the patient with immunotherapy against their cancer.
The Molecular Analysis for Therapy Choice (NCI-MATCH) clinical trial was sponsored by…
Faster workflows boost drug discovery in natural product-based screening
Posted 7/26/2023Plants, marine invertebrates, and microbes have been a major source of novel drugs against cancer, viruses, and fungal diseases. New isolation methods are making it faster and easier to discover these natural products.
To encourage ongoing drug development from natural products, a collaboration of government and contractor scientists demonstrated accelerated methods of…
Two key drivers of hereditary kidney cancer are identified
Laboratory Animal Sciences ProgramPosted 7/13/2023An international research collaboration including scientists from the Frederick National Laboratory has identified two key drivers of a hereditary kidney cancer and opened new possibilities for therapeutic approaches to a disease whose current treatment is largely surgerical.
The scientists implicated two proteins that work cooperatively to drive tumor formation in Birt-…
Panel at BIO International Convention provides navigation tips and resources to avoid AI pitfalls
Partnership Development Office, Center for Innovation and Strategic PartnershipsPosted 7/10/2023Artificial intelligence has rapidly become a buzzword that evokes fear and hope. A recent panel discussion dug into this issue at the 2023 BIO International Convention, one of the world’s largest biotech partnering events, attracting more than 14,000 biotech leaders to Boston this year.
The discussion, “Is Your Billion-Dollar Oncology AI Cutting-Edge Technology or Is It…
National Science Foundation grant provides PhD student experience with machine learning under FNL mentor
Cancer Data Science Initiatives, Partnership Development OfficePosted 6/27/2023
When Chloe Thangavelu, a Ph.D. student at the University of California, Irvine, received funding from the National Science Foundation for a six-month internship, she eagerly set out to find an internship where she could combine her biological and computational expertise and gain experience with machine learning.
That’s why she reached out to the Frederick National…
Clinical Safety Office supports patient safety monitoring for mpox clinical trial in Africa
Clinical Monitoring Research ProgramPosted 6/13/2023
A new clinical study in Africa is testing an antiviral treatment for patients with mpox (previously known as monkeypox). This is the latest project for the Frederick National Laboratory for Cancer Research’s Clinical Monitoring Research Program, which specializes in supporting clinical trials in domestic and international settings.
The Clinical Safety Office, under…
First study of people with HIV on long-term ART shows cognitive decline
Posted 6/7/2023People with HIV on long-term antiretroviral therapy show signs of brain damage and cognitive impairment on a battery of imaging, laboratory, and functional tests, and they report a greater degree of difficulty with the routine tasks of everyday life, according to a new study.
The study, published in April in the journal Neurology, is the first to gauge cognitive changes in…
Study on blood tests to guide cancer treatment to be presented at 2023 ASCO Annual Meeting
Molecular Characterization LaboratoryPosted 6/1/2023Blood-based tests that identify cancer markers may offer a non-invasive way to determine if a patient is a candidate for immunotherapy, according to a Frederick National Laboratory for Cancer Research study to be presented at the 2023 Annual Meeting of the American Society for Clinical Oncology, June 2-6 in Chicago.
Chris Karlovich, Ph.D. of the Frederick National…
Biotech Connector recap: Shedding light on human maladies
Center for Innovation and Strategic Partnerships, RAS InitiativePosted 6/1/2023Three scientists from the region presented innovative imaging techniques and discussed how they are leveraging them to advance cancer research and ultimately improve human health at the Biotech Connector seminar on Wednesday, May 17, the second in this year’s series sponsored by the Frederick National Laboratory for Cancer Research and the Frederick County Chamber of Commerce…